alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 

Thomas C. Mitchell (CA State Bar No. 124438) 

ORRICK, HERRINGTON & SUTCLIFFE LLP 

405 Howard Street 

San Francisco, CA 94105 

Telephone: (415) 773-5732 

Facsimile: (415) 773-5759 

Email: tcmitchell@orrick.com 

Debra L. Felder (admitted pro hac vice) 

ORRICK, HERRINGTON & SUTCLIFFE LLP 

1152 15th Street, NW 

Washington, DC 20005 

Telephone: (202) 339-8567 

Facsimile: (202) 339-8500 

Email: dfelder@orrick.com 

Counsel for mNOC AERS LLC

IN THE UNITED STATES BANKRUPTCY COURT 

FOR THE NORTHERN DISTRICT OF CALIFORNIA 

SAN FRANCISCO DIVISION 

In re: 

PG&E CORPORATION, 

 -andPACIFIC GAS AND ELECTRIC 

COMPANY, 

Debtors.

 Affects PG&E Corporation 

 X Affects Pacific Gas and Electric Company 

 Affects both Debtors 

*All papers shall be filed in the Lead Case, 

 No. 19-30088-DM.

Bankruptcy Case 

Case No. 19-30088 (DM) 

 Chapter 11 

 (Lead Case) 

 (Jointly Administered) 

 ORDER GRANTING mNOC AERS 

 LLC’S MOTION UNDER 11 §§ 

 105(A) AND 107(B) AND FRBP 9018 

 FOR ENTRY OF AN ORDER 

 AUTHORIZING THE FILING OF 

 CERTAIN DOCUMENTS AND 

 RELATED FILINGS UNDER SEAL

 Related Docket Nos. 1596 and 1599 

Signed and Filed: April 24, 2019

________________________________________

DENNIS MONTALI

U.S. Bankruptcy Judge

Entered on Docket 

April 24, 2019

EDWARD J. EMMONS, CLERK 

U.S. BANKRUPTCY COURT 

NORTHERN DISTRICT OF CALIFORNIA

Case: 19-30088 Doc# 1654 Filed: 04/24/19 Entered: 04/24/19 15:38:35 Page 1 of

2
2 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 

Upon mNOC AERS LLC’s (“mNOC”) Motion and Memorandum of Points and Authorities 

Under 11 U.S.C. §§ 105(a) and 107(b) and FRCP 9018 for Entry of An Order Authorizing the 

Filing of Certain Documents and Related Filings Under Seal, dated April 22, 2019 (the “Motion 

to File Under Seal”) (Dkt. 1596),1

IT IS HEREBY ORDERED THAT: 

1. The Motion to File Under Seal is granted. 

2. mNOC is authorized to file the CSA and unredacted copies of the Motion Papers 

under seal pursuant to Section 107(b) of the Bankruptcy Code and Bankruptcy Rule 9018. 

3. The CSA and the unredacted Motion Papers are confidential, shall remain under 

seal, and shall not be made available to anyone without the consent of mNOC and the parties 

thereto, except that copies shall be provided to the Court on a strictly confidential basis. 

4. Notwithstanding Bankruptcy Rule 6004(h), the terms and conditions of this Order 

shall be immediately effective and enforceable upon its entry. 

5. mNOC is authorized to take all steps necessary or appropriate to carry out this Order. 

6. This Court shall retain jurisdiction to hear and determine all matters arising from or 

related to the implementation, interpretation, or enforcement of this Order. 

**END OF ORDER** 

1

 Capitalized terms used but not otherwise herein defined shall have the meanings ascribed to them in the 

Motion to File Under Seal. 

Case: 19-30088 Doc# 1654 Filed: 04/24/19 Entered: 04/24/19 15:38:35 Page 2 of

2
Fourth Court of Appeals

San Antonio, Texas

May 26, 2016

No. 04-16-00105-CV

IN THE INTEREST OF A.M.W., A CHILD,

From the 57th Judicial District Court, Bexar County, Texas

Trial Court No. 1995EM501946

The Honorable Nick Catoe, Jr., Judge Presiding

O R D E R

The reporter’s record in this case was electronically recorded. On May 2, 2016 we 

ordered the court recorder to file the audiotapes, logs, and the transcript of the proceedings on or 

before May 27, 2016. The audiotape and log were filed on May 4, 2016. 

On May 25, 2016, a notification of late record was filed stating that the transcript was 

expected to be completed by June 10, 2016. An extension of time to file the transcript is 

GRANTED. The transcript is due on June 10, 2016.

_________________________________

Karen Angelini, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 26th day of May, 2016.

___________________________________

Keith E. Hottle

Clerk of Court
106TH CONGRESS

1ST SESSION S. 1996

AN ACT

To amend the Public Health Service Act to clarify provisions

relating to the content of petitions for compensation

under the vaccine injury compensation program.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

S 1996 ES

1 SECTION 1. AMENDMENT TO THE PUBLIC HEALTH SERVICE

2 ACT.

3 Section 2111(c)(1)(D) of the Public Health Service

4 Act (42 U.S.C. 300aa-11(c)(1)(D)) is amended by striking

5 ‘‘and’’ at the end and inserting ‘‘or (iii) suffered such ill6 ness, disability, injury or condition from the vaccine which

7 resulted in inpatient hospitalization and surgical interven8 tion to correct such illness, disability, injury or condition,

9 and’’.

Passed the Senate November 19, 1999.

Attest:

Secretary.
106TH CONGRESS

1ST SESSION S. 1996

AN ACT

To amend the Public Health Service Act to clarify

provisions relating to the content of petitions forcompensation under the vaccine injury compensation program.
EXHIBIT 23.2

CONSENT OF SRK CONSULTING (U.S.), INC.

We hereby consent to the incorporation by reference of any mineralized material and other analyses performed by us in our capacity as
an independent consultant to Golden Minerals Company (the "Company"), which are set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2009, in
the Company's Registration Statement on Form S-8 (No. 333-159096), any prospectuses or amendments or supplements thereto, and in any amendment to any of the
foregoing.

Date: March 29, 2010

SRK CONSULTING (U.S.), INC./s/ LEAH MACHName: Leah MachTitle: Principal Resource Geologist


---



QuickLinks
Exhibit B page 51 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 1

of 25
Exhibit B page 52 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 2

of 25
Exhibit B page 53 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 3

of 25
Exhibit B page 54 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 4

of 25
Exhibit B page 55 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 5

of 25
Exhibit B page 56 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 6

of 25
Exhibit B page 57 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 7

of 25
Exhibit B page 58 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 8

of 25
Exhibit B page 59 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 9

of 25
Exhibit B page 60 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 10

of 25
Exhibit B page 61 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 11

of 25
Exhibit B page 62 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 12

of 25
Exhibit B page 63 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 13

of 25
Exhibit B page 64 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 14

of 25
Exhibit B page 65 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 15

of 25
Exhibit B page 66 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 16

of 25
Exhibit B page 67 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 17

of 25
Exhibit B page 68 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 18

of 25
Exhibit B page 69 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 19

of 25
Exhibit B page 70 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 20

of 25
Exhibit B page 71 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 21

of 25
Exhibit B page 72 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 22

of 25
Exhibit B page 73 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 23

of 25
Exhibit B page 74 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 24

of 25
Exhibit B page 75 of 166

Case: 19-30088 Doc# 2073-4 Filed: 05/17/19 Entered: 05/17/19 15:12:07 Page 25

of 25
EXHIBIT
32.1







CERTIFICATION
OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER


PURSUANT
TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT


TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Zhaoheng Hydropower Company (the
“Company”) on Form 10-Q for the quarter ended June 30, 2008, as filed with the
Securities and Exchange Commission on the date therein specified (the “Report”),
the undersigned, Guosheng Xu, Chief Executive Officer and Acting Principal
Financial Officer of the Company, certifies pursuant to 18 U.S.C. Section 1350
as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002,
that:





(1)           The
Report fully complies with the requirements of Section 13(a) or 15(d), as
applicable, of the Securities Exchange Act of 1934, and





(2)           The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.








Dated:  August
      14, 2008
            
            /s/
      Guosheng
      XuGuosheng
      Xu, Chief Executive Officer and Acting Principal Financial
      Officer
#### THE PEOPLE OF THE STATE OF NEW YORK, Respondent, *v.*LIPMAN ARENSBURG, Appellant.

*Bale of animal fat, colored to resemble butter*—1885, *chap.*183, *sec. 7, as amended by sec. 2 of chap.*458 *of*1885.

The -defendant kept for sale and sold, as oleomargarine, a white product of animal fat so colored as to imitate and resemble natural butter.

*Held,*that he was guilty of a misdemeanor in violating the provisions of section 7 of chapter 183 of 1885, as amended by section *2*of chapter 458 of 1885. (Pratt, J., dissenting.)

Appeal by the defendant from a conviction and judgment of the Court of Sessions of Kings county.

The defendant sold a substance, the product of animal fat, colored in imitation or semblance of natural butter. The person purchasing it asked for oleomargarine and it was sold to him as such. The defendant was engaged in the oleomargarine business and had on the outside of his place of business a sign with the word *“*Oleomargarine” thereon.

*359
      *F. R. Coudert, Wheeler H. Peckham, John N. Lewis,*for the appellant.

*James W. Ridgway,*district attorney, for the respondent.

Barnard, P. J.:

The legislature is the guardian of the public health not only, but is the protector of citizens against fraud and imposition. By chapter 183, Laws of 1885, and amended by chapter 458, Laws of 1885, it was enacted that no person shall manufacture, except from unadulterated milk and cream, any product *“*in imitation or semblance of ” natural butter made from cream, nor shall he sell any article produced in violation of that act. The defendant sold a compound in violation of this act. A dead white product of animal fat is so colored as to resemble butter. It is not sold as butter in this ease, ■but as oleomargarine; but it was an imitation of butter, and purposely made so.' The legislature has power to prohibit a fraud — a simulation of a healthy article of food, and one which is so universally consumed by the people.

The Court of Appeals condemned a law which prohibited the manufacture of an article designed to take the place of butter, but the court seems to make a distinction between manufacturing a compound from tallow or other fats to take the place of butter and the sale of the same compound so colored as to be an imitation of butter. *(People*v. *Marx,*99 N. Y., 377.)

The case of the *People*v. *Kerin*(39 Hun, 631) is not in conflict with this view of the statute. In that case the accused purchased the adulteration as dairy butter, and sold it as such, believing it to be dairy butter. The case presented is. one entirely different. The simulated compound is bought and sold as oleomargarine, but is so made as to deceive by a false color. If oleomargarine may be made, let it present no false appearance.” '•

Judgment affirmed.

DyeMAN, J., concurred.

Pratt, J.:

It seems to me this case cannot, in principle, be distinguished from case lately decided by Court of Appeals. I therefore dissent.

Conviction and judgment affirmed.
ACTIONS OF THE MARCH 9, 2021, EXECUTIVE COMMITTEE MEETING

VOTED that the Executive Committee recommends that the Board of Regents confers the title 

of Regent Emerita on France A. Córdova with deep gratitude for the outstanding service she 

provided, and will continue to provide, to the Board of Regents and the Smithsonian Institution.
**Exhibit
      32(a)**


**Certification
        of**
 **Chief
        Executive Officer**
 **Of
        99¢ Only Stores**
  This
            certification is provided pursuant to Section 906 of the Sarbanes-Oxley
            Act of
            2002 and accompanies the annual report on Form 10-K (the "Report") for
            the
            period ended December 31, 2004 of 99¢ Only Stores (the "Issuer").
  I,
              Eric
              Schiffer, the Chief Executive Officer of Issuer certify that:
  (i)
                the
                Report fully complies with the requirements of section 13(a) or section
                15(d) of
                the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d));
                and
  (ii)
                  the
                  information contained in the Report fairly presents, in all material
                  respects,
                  the financial condition and results of operations of the Issuer.
   Dated:
                              September 8, 2005By:
                            /s/ Eric SchifferName:
                            Eric
                                SchifferTitle:
                            Chief
                                Executive Officer
**Exhibit 32.1**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Amendment to the Annual Report of AdvanSource Biomaterials Corporation, a Delaware corporation (the “Company”), on Form 10-K/A for the fiscal year ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael F. Adams, Chief Executive Officer and President of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

| Date: July 29, 2016

 

 

 

/s/ Michael F. Adams

 

Michael F. Adams

 

Chief Executive Officer and President

 

This certification accompanies each report of the Company on Form 10-Q and Form 10-K pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by §906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Exhibit 21
----------
The following is a list of wholly owned subsidiaries, unless otherwise noted, of
FPIC Insurance Group, Inc. as of December 31, 2001:


Name of Subsidiary                                        State of Incorporation
------------------                                        ----------------------

First Professionals Insurance Company, Inc. (First
Professionals)                                                Florida

Anesthesiologists Professional Assurance Company              Florida

FPIC Insurance Agency, Inc.                                   Florida

McCreary Corporation                                          Florida

Employers Mutual, Inc.                                        Florida

FPIC Services, Inc.                                           Florida

Professional Strategy Options, Inc.                           Florida

Administrators For The Professions, Inc. (AFP)                New York

Group Data Corporation                                        New York
(100% owned by AFP)

FPIC Intermediaries, Inc.                                     New York
(100% owned by AFP)

The Tenere Group, Inc. (Tenere)                               Missouri
(100% owned by First Professionals)

Intermed Insurance Company (Intermed)                         Missouri
(100% owned by Tenere)

Trout Insurance Services, Inc.                                Missouri
(100% owned by Intermed)

Interlex Insurance Company                                    Missouri
(100% owned by Intermed)

Insurance Services, Inc.                                      Missouri
(100% owned by Intermed)
**Exhibit 32.2**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of AdvanSource Biomaterials Corporation, a Delaware corporation (the “Company”), on Form 10-K for the fiscal year ended March 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David Volpe, the chief financial officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

| Date: July 15, 2013

 

 

 

/s/ David Volpe

 

David Volpe

 

Chief Financial Officer

 

 

This certification accompanies each report of the Company on Form 10-Q and Form 10-K pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by §906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE AUDITED
FINANCIALS IN 10-K AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                          26,693
<SECURITIES>                                         0
<RECEIVABLES>                                    2,963
<ALLOWANCES>                                      (92)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                30,007
<PP&E>                                           2,980
<DEPRECIATION>                                   2,159
<TOTAL-ASSETS>                                  33,155
<CURRENT-LIABILITIES>                            3,496
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            15
<OTHER-SE>                                      29,602
<TOTAL-LIABILITY-AND-EQUITY>                    33,155
<SALES>                                          4,816
<TOTAL-REVENUES>                                 4,816
<CGS>                                                0
<TOTAL-COSTS>                                    5,190
<OTHER-EXPENSES>                                10,640
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (4,202)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (4,202)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (4,202)
<EPS-PRIMARY>                                    (.29)
<EPS-DILUTED>                                    (.29)
        

</TABLE>
#### Emma J. Weber, Respondent, v. Citizens’ Trust Company of Utica, N. Y., Appellant.

Judgment and order affirmed, with costs.

All concurred, except Williams, J., who dissented.